rs878972

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000259206.9(IL1RN):​c.73+8A>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 1,604,640 control chromosomes in the GnomAD database, including 56,618 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4070 hom., cov: 30)
Exomes 𝑓: 0.26 ( 52548 hom. )

Consequence

IL1RN
ENST00000259206.9 splice_region, intron

Scores

2
Splicing: ADA: 0.00002619
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.149

Publications

15 publications found
Variant links:
Genes affected
IL1RN (HGNC:6000): (interleukin 1 receptor antagonist) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
IL1RN Gene-Disease associations (from GenCC):
  • sterile multifocal osteomyelitis with periostitis and pustulosis
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 2-113120136-A-C is Benign according to our data. Variant chr2-113120136-A-C is described in ClinVar as Benign. ClinVar VariationId is 330822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1RNNM_173841.3 linkc.73+8A>C splice_region_variant, intron_variant Intron 2 of 5 NP_776213.1 P18510-3
IL1RNNM_000577.5 linkc.10+2108A>C intron_variant Intron 1 of 4 NP_000568.1 P18510-2
IL1RNNM_001318914.2 linkc.-210+8A>C splice_region_variant, intron_variant Intron 2 of 6 NP_001305843.1 P18510-4A0A024R528

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1RNENST00000259206.9 linkc.73+8A>C splice_region_variant, intron_variant Intron 2 of 5 1 ENSP00000259206.5 P18510-3
IL1RNENST00000354115.6 linkc.10+2108A>C intron_variant Intron 1 of 4 1 ENSP00000329072.3 P18510-2
IL1RNENST00000361779.7 linkc.-209-1312A>C intron_variant Intron 1 of 5 1 ENSP00000354816.3 P18510-4

Frequencies

GnomAD3 genomes
AF:
0.210
AC:
31746
AN:
151264
Hom.:
4064
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0610
Gnomad AMI
AF:
0.244
Gnomad AMR
AF:
0.274
Gnomad ASJ
AF:
0.286
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.303
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.269
Gnomad OTH
AF:
0.229
GnomAD2 exomes
AF:
0.253
AC:
63662
AN:
251238
AF XY:
0.256
show subpopulations
Gnomad AFR exome
AF:
0.0536
Gnomad AMR exome
AF:
0.317
Gnomad ASJ exome
AF:
0.295
Gnomad EAS exome
AF:
0.0945
Gnomad FIN exome
AF:
0.304
Gnomad NFE exome
AF:
0.266
Gnomad OTH exome
AF:
0.266
GnomAD4 exome
AF:
0.263
AC:
382285
AN:
1453256
Hom.:
52548
Cov.:
29
AF XY:
0.263
AC XY:
190375
AN XY:
723634
show subpopulations
African (AFR)
AF:
0.0499
AC:
1664
AN:
33340
American (AMR)
AF:
0.313
AC:
13981
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
7472
AN:
26076
East Asian (EAS)
AF:
0.101
AC:
3990
AN:
39668
South Asian (SAS)
AF:
0.282
AC:
24268
AN:
86086
European-Finnish (FIN)
AF:
0.298
AC:
15917
AN:
53408
Middle Eastern (MID)
AF:
0.218
AC:
1244
AN:
5696
European-Non Finnish (NFE)
AF:
0.270
AC:
298606
AN:
1104170
Other (OTH)
AF:
0.252
AC:
15143
AN:
60100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
13059
26119
39178
52238
65297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9890
19780
29670
39560
49450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.210
AC:
31763
AN:
151384
Hom.:
4070
Cov.:
30
AF XY:
0.212
AC XY:
15694
AN XY:
73864
show subpopulations
African (AFR)
AF:
0.0609
AC:
2512
AN:
41244
American (AMR)
AF:
0.275
AC:
4172
AN:
15158
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
994
AN:
3470
East Asian (EAS)
AF:
0.104
AC:
540
AN:
5174
South Asian (SAS)
AF:
0.288
AC:
1376
AN:
4772
European-Finnish (FIN)
AF:
0.303
AC:
3157
AN:
10404
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.269
AC:
18242
AN:
67856
Other (OTH)
AF:
0.231
AC:
485
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1174
2347
3521
4694
5868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.239
Hom.:
2870
Bravo
AF:
0.199
Asia WGS
AF:
0.202
AC:
703
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 49% of patients studied by a panel of primary immunodeficiencies. Number of patients: 47. Only high quality variants are reported. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sterile multifocal osteomyelitis with periostitis and pustulosis Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
5.0
DANN
Benign
0.37
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000026
dbscSNV1_RF
Benign
0.0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878972; hg19: chr2-113877713; COSMIC: COSV52080718; COSMIC: COSV52080718; API